Continuing Care Following Drug Abuse Treatment: Linkage With Primary Care
- Conditions
- Alcohol AbuseSubstance AbuseSubstance, AddictionSubstance Dependence
- Interventions
- Behavioral: Linkage patient activation intervention
- Registration Number
- NCT01621711
- Lead Sponsor
- Kaiser Permanente
- Brief Summary
This component of a larger Center of Research Excellence Grant improves treatment for drug abuse by developing effective linkages between specialty drug treatment and primary health care.
- Detailed Description
This is a longitudinal two-arm quasi-experimental 3-month alternating off/on design over a 30 month period in which, after a random start, the Linkage condition alternately is added to Usual Care in the Chemical Dependency (CD) clinic and then removed. We compare Usual Care to Usual Care plus Linkage. Follow-up interviews will be conducted at 6, 12 and 24 months. The Linkage intervention includes Usual Care plus 1) sessions on activation regarding overall health behaviors and on selecting a Primary Care physician and communicating with him/her, and 2) a linkage phone call (and/or a facilitated email) with the patient, clinician, and Primary Care physician. The intervention aims to place drug abuse problems in the context of overall health and health care and to activate patients to increase involvement in their own health care.
Recruitment & Eligibility
- Status
- ACTIVE_NOT_RECRUITING
- Sex
- All
- Target Recruitment
- 504
- Research participants will be adult patients at the Kaiser Permanente San Francisco Chemical Dependency Recovery Program, who have completed 2 weeks of treatment.
- Patients with a diagnosis of dementia, mental retardation, or who are actively psychotic or suicidal will be excluded by their clinician.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Linkage patient activation intervention Linkage patient activation intervention Usual Care with the exception that the six 45-min Linkage patient activation education groups replaced the six 45-min Usual Care medical education groups, plus a linkage phone call (and/or a facilitated email) with the patient, clinician, and Primary Care physician.
- Primary Outcome Measures
Name Time Method patient engagement in health care (including patient portal use, familiarity and satisfaction with Primary Care physician, and CD treatment length of stay) 6 months post baseline Measured by data from interviews and Electronic Health Record (EHR)
patient activation measure 6 months post baseline Measured by Patient Activation Measure (PAM) from interview data
Substance use and mental health outcomes 6 months post baseline Measures include past 30-day alcohol, drug and total abstinence; Patient Health Questionnaire (PHQ-9) and Addiction Severity Index using interview data
- Secondary Outcome Measures
Name Time Method patient engagement in health care at 12 and 24 months 12 and 24 months post baseline Measured by data from interviews and Electronic Health Record (EHR)
Substance use and mental health outcomes at 12 and 24 months 12 and 24 months post baseline Measures include past 30-day alcohol, drug and total abstinence; Patient Health Questionnaire (PHQ-9) and Addiction Severity Index using interview data
Health care utilization and cost 12 and 24 months post baseline Measured by data from interviews and adminstrative data
patient activation measure at 12 and 24 months 12 and 24 months post baseline Measured by Patient Activation Measure (PAM) from interview data
Trial Locations
- Locations (1)
Kaiser Permanente, Chemical Dependency Recovery Program
🇺🇸San Francisco, California, United States